Alnylam Pharmaceuticals: Citigroup cuts target price to $320 from $340
ALNY•Citigroup cut its target price for Alnylam Pharmaceuticals to $320 from $340.
Related News
Chord Energy Corporation: Wells Fargo cuts target price to $174 from $175
CHRD•
Bank of America third-quarter profit falls on $1.2 billion fine
BAC•
Energy Fuels target price cut to $14 from $18
UUUU•
Magnolia Oil & Gas target price cut to $30 from $36
MGY•
National Fuel Gas plans spin-off of integrated upstream and gathering business by H2 2027
NFG•